Article Per Year (5 Year)
p-Index From 2021 - 2026
2.983
P-Index
This Author published in this journals
All Journal International Journal of Integrative Sciences International Journal of Scientific Multidisciplinary Research (IJSMR) International Journal of Applied Economics, Accounting and Management (IJAEAM) Contemporary Journal of Applied Sciences (CJAS) International Journal of Natural and Health Sciences
Asghar Mehdi
Unknown Affiliation
Religion Civil Engineering, Building, Construction & Architecture Computer Science & IT Decision Sciences, Operations Research & Management Earth & Planetary Sciences Economics, Econometrics & Finance Education Environmental Science Health Professions Industrial & Manufacturing Engineering Law, Crime, Criminology & Criminal Justice Mechanical Engineering Medicine & Pharmacology Social Sciences

Published : 23 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 23 Documents
Search

 1   2   3 
The Impact of Current Trends in Health Care on the Pharmaceutical Sales Force of the Future Haider, Rehan; Asghar Mehdi; Anjum Zehra; Geetha Kumari Das; Zameer Ahmed; Sambreen Zameer
International Journal of Natural and Health Sciences Vol. 2 No. 2 (2024): April 2024
Publisher : MultiTech Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59890/ijnhs.v2i2.1260

Abstract

Drug manufacturing is undergoing a life-changing development compelled by current flows in healthcare. This abstract explores the deep impact of these styles on the drug auction force of the future. The convergence of science, switching healthcare examples, and developing patient expectations is changing the countryside at which point drug companies run. One main style is the growing focus on embodied cures and point-in-direction therapies. Advances in genomics and the accuracy of cures are changing the way diseases are pronounced and medicated, making it necessary to have a deep understanding of these complex changes. The marketing lawyers of the future must be outfitted to communicate the profit of these tailor-made situations to healthcare pros and navigate complicated experimental disputes. Additionally, the rise of mathematical health forms and telemedicine is changing the established buying model. As virtual interplays become more widespread, pharmaceutical demand counselors must become accustomed to doing business with healthcare professionals through mathematical channels. This demands an ability set that blends mechanics proficiency with productive ideas. Moreover, the emphasis on patient-in-the-middle care is a fluctuating administrative movement. The pharmaceutical reduction force of the future must not only use accompanying healthcare providers but also connect with conversant and enabled inmates. Building relationships with subjects and providing valuable news for further traditional device analyses will be critical for their benefit. In conclusion, the evolving healthcare landscape is changing the role of the drug sales force
Mastitis Rehan Haider; Asghar Mehdi; Geetha Kumari; Zameer Ahmed; Sambreen Zameer
Contemporary Journal of Applied Sciences Vol. 2 No. 1 (2024): January 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/cjas.v2i1.9315

Abstract

Mastitis, an inflammatory condition of the mammary gland, remains a major issue for both human and animal fitness. In addition to affecting lactating women, mastitis adversely affects milk manufacturing, animal welfare, and animal welfare. This method offers a concise evaluation of mastitis, highlighting its etiology, clinical manifestations, and mitigation techniques.Mastitis usually results from bacterial infections, with Staphylococcus aureus, Streptococcus spp., and Escherichia coli being the most common causative organisms. Infection occurs due to the activation of the immune reaction, which is fundamental to neighborhood swelling, pain, warmth, and altered milk composition. Clinical signs and symptoms include modifications in milk appearance, consistency, and the presence of systemic symptoms, including fever and lethargy.Timely diagnosis is vital for powerful control. Modern methods include somatic cell counts, bacterial lifestyles, and molecular strategies to identify causative pathogens. Advances in omics technologies have provided a deeper understanding of host-pathogen interactions, assisting in the development of patient-centered interventions.The preventive measures involve a multidisciplinary approach. More advantageous milking hygiene, proper teat care, and regular fitness tracking can mitigate the threat of mastitis
The Challenges and Future of Advanced Therapies Rehan Haider; Asghar Mehdi; Geetha Kumari; Zameer Ahmed; Sambreen Zameer
Contemporary Journal of Applied Sciences Vol. 2 No. 1 (2024): January 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/cjas.v2i1.9343

Abstract

Advanced therapies, including gene therapies, cell-based therapies, and tissue engineering, have emerged as revolutionary approaches in medicine. These therapies hold immense promise for treating previously untreatable diseases by targeting underlying causes at the molecular and cellular levels. However, their translation from laboratory breakthroughs to clinical applications is accompanied by significant challenges that must be addressed to realize their full potential. One major challenge lies in the complexity and variability of patient responses. The personalized nature of advanced therapies demands precise customization of each individual, necessitating the development of robust biomarkers and predictive models. Ensuring the safety of these therapies is paramount. Unforeseen immune reactions, off-target effects, and long-term consequences require stringent preclinical testing and vigilant post-market surveillance. Manufacturing scalability is another hurdle. Unlike traditional pharmaceuticals, advanced therapies often involve intricate processes specific to each patient. Standardizing and automating these processes, while maintaining product quality and consistency, are critical obstacles. Moreover, the high costs associated with research, development, manufacturing, and delivery hinder accessibility and affordability, raising concerns about equitable patient access. The regulatory landscape also requires adaptation to accommodate the unique attributes of advanced therapies. Striking a balance between timely access to patients and comprehensive evaluation of safety and efficacy challenges regulatory agencies globally
The Role of Digital Marketing in Pharmaceutical Search Engine Reputation Management (SERM) Rehan Haider; Asghar Mehdi; Geetha Kumari; Zameer Ahmed; Sambreen Zameer
Contemporary Journal of Applied Sciences Vol. 2 No. 1 (2024): January 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/cjas.v2i1.9392

Abstract

The function of Digital marketing in pharmaceutical Search Engine Reputation Management (SERM) is progressively important in forming the online visibility and credibility of pharmaceutical companies. This paper explores how  digital marketing strategies are employed within Pharmaceutical Industry  to manage and reinforce connected internet opinions efficiently. Digital marketing resorts to different channels, including search engine optimization (SEO), friendly publishing, content marketing, and online billing, to reach and join accompanying cases and healthcare professionals. SERM focuses on the full enthusiasm for administering a company’s name through these digital channels, guaranteeing that definite and correct facts about pharmaceutical production and parties dominate the computer program that searches results.Key SERM strategies include listening to internet mentions, directing reviews, addressing negative responses, and engaging SEO methods to advance favorable content. By mixing these methods, drug companies can safeguard their influences, build trust, and guarantee agreement accompanying regulatory flags. This paper checks current practices, case studies, and moral considerations in pharmaceutical digital marketing  and SERM. It focuses on best practices and innovative approaches that improve brand perceptibility and patient data while asserting high flags of honor and supervisory compliance
Recommended Diet for Diabetics Hydrocarbons, Glycemic Impact, Glycemic Load, Glycemic Index, and Mediterranean Diet Rehan Haider; Asghar Mehdi; Geetha Kumari; Zameer Ahmed; Sambreen Zameer
Contemporary Journal of Applied Sciences Vol. 2 No. 2 (2024): February 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/cjas.v2i2.9433

Abstract

The growing prevalence of diabetes has necessitated the development of effective digestive blueprints to increase blood glucose levels and improve overall well-being. This study aimed to determine the impact of various dietary elements and abstinence from food patterns on glycemic control in diabetic inmates. Specifically, it tests the parts of hydrocarbons, glycemic impact, glycemic load, glycemic index, and the ability of the Mediterranean diet to consume diabetes. The research methodology involved an inclusive composition review and meta-reasoning of the existing studies that concentrated on these factors. Data were obtained from dispassionate tests, practical studies, and digestive directions written in peer-reviewed journals. The verdicts indicate that diets high in complex carbohydrates and texture, accompanied by a reduced glycemic index and glycemic load, are advantageous in controlling blood glucose levels. The Mediterranean diet, resulting from the extreme use of products that produce whole grains and healthy fats, is specifically productive for reconstructing glycemic control and lowering cardiovascular risk determinants. Furthermore, the study highlights the significance of the individualized ability to consume pieces of advice to establish the glycemic reaction of various cookings, seeing the variability in individual metabolic reactions. The results imply that merging these digestive elements into regular food planning can considerably improve diabetes administration and overall well-being
AIDS Activism and the Pharmaceutical Industry Rehan Haider; Asghar Mehdi; Geetha Kumari; Zameer Ahmed; Sambreen Zameer
Contemporary Journal of Applied Sciences Vol. 2 No. 2 (2024): February 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/cjas.v2i2.9461

Abstract

The intersection of AIDS activism and the pharmaceutical industry has been pivotal in remodeling public health responses and treatment accessibility for HIV/AIDS. In the Eighties and Nineteen Nineties, AIDS activists and considerable organizations like ACT UP played an essential role in the pharmaceutical industry's regulations and practices. these activists demanded quicker drug approval methods, low-cost medicinal drug pricing, and increased transparency in clinical trials. Their advocacy brought about extensive policy adjustments, which included the elevated approval process by using the U.S. Meals and Drug Administration (FDA) and the implementation of the 340B Drug Pricing application, which made medicines less expensive for underserved populations.The activism now not only compelled pharmaceutical industry to lower expenses but additionally stimulated the enterprise's research and improvement priorities, resulting in an extra-targeted attempt at HIV/AIDS remedies. Furthermore, the collaboration among activists, scientists, and healthcare providers fostered an environment conducive to large scientific breakthroughs, inclusive of the improvement of antiretroviral remedies (art), which has converted HIV/AIDS from a deadly disease to a doable, persistent situation.This dynamic interaction between activism and industry highlights the significance of civic engagement in shaping healthcare coverage and advancing scientific research
Obesity Current Research and Future Hope Rehan Haider; Asghar Mehdi; Geetha Kumari
Contemporary Journal of Applied Sciences Vol. 2 No. 2 (2024): February 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/cjas.v2i2.9573

Abstract

Obesity is a broad-based public health issue that is defined by excessive consumption of body fat, which is associated with more negative health impacts than positive ones, such as diabetes, cancer, and cardiovascular disease. This abstract backs up a brief overview of the approaches being used in the fight against obesity today and in the future.The goal of current research efforts is to comprehend the intricate interplay of behavioral, environmental, and historical factors that contribute to corpulence. Genetic research has uncovered a large number of vulnerable genes, removing the inherited components of obesity. In the meanwhile, material factors like fattening diets and indolent habits warrant more study.Approaches to behavior qualification and novel healing attacks are being energetically investigated. Strategies include expanding anti-corpulence medications, bariatric surgery, and targeting gut bacteria. In the areas of precision, treatment, customized digestive approvals, plant structure, and customized absorption, encouraging results are emerging.The integration of scientific and mathematical strength techniques holds the key to future success in the battle against obesity. Innovative approaches to tracking and managing obesity are provided by wearable technology, mobile devices, and telehealth manifestos. Healthcare providers and situations can benefit from the large dossier science of logical analysis and artificial intelligence in generating thoughtful remedies for individualized burden administration
Antitumor Necrosis Factor-α Drugs and Disease-Modifying Antirheumatic Drugs for Low Back Pain Rehan Haider; Asghar Mehdi
International Journal of Scientific Multidisciplinary Research Vol. 1 No. 11 (2023): December 2023
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/ijsmr.v1i11.6412

Abstract

The widespread and often debilitating ailment known as low back pain (LBP) is a significant worldwide energy concern. Despite its diversity, the pathophysiology of LBP is significant for attraction, incidence, and persistence. Currently, there is a growing interest in investigating the use of disease-modifying anti-rheumatic medicines (DMARDs) and anti-tumor necrosis factor-α (TNF-α) medications as prospective therapeutic alternatives for managing LBP, especially in cases where the angering component is evident. A proinflammatory cytokine called TNF-α is present in various chronic pain situations that entail LBP. TNF-α inhibitors, typically used secondary in conditions like rheumatoid arthritis, have been demonstrated to reduce pain and inflammation in people with low back pain. Similarly, DMARDs have been purposefully introduced due to their ability to alleviate LBP. They do this by harmonizing the invulnerable reaction and occupying antagonistic-instigative belongings. This abstract highlights the role of DMARDs and TNF-α inhibitors in the instigative component of the illness and describes how they work in the administration of LBP. This emphasizes how several learning approaches must be combined in order to administer LBP because these medications are guided by potential antagonistic possessions and embodied situation designs. It also discusses ongoing, objective issues and guidelines meant to provide evidence-based justifications for their application in LBP. Although DMARDs and TNF-α inhibitors show promise as LBP treatments, more study is needed to confirm their long-term safety and efficacy. As our comprehension of the intricate pathophysiology of LBP deepens, these pharmacological incursions allow us to improve useful approaches in comprehensive treatment of this contentious illness
The History of Diabetes Mellitus Rehan Haider; Asghar Mehdi
International Journal of Scientific Multidisciplinary Research Vol. 1 No. 10 (2023): November 2023
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/ijsmr.v1i10.6494

Abstract

Diabetes mellitus, an incessant metabolic disorder caused by increased blood glucose levels, has a rich and complex history spanning paradise. The first famous reference to diabetes dates back to ancient Egypt, where the condition was defined in healing texts around 1500 BCE. However, it was not just before the 19th century that important progress had been made in understanding and directing diabetes. In 1889, two German physicians, Joseph von Mering, and Oskar Minkowski, fashioned an important finding by professing that the removal of organ meat in dogs caused diabetes-like manifestations. This led to the identification of organ meat as an insulin source. In 1921, a Canadian group led by Frederick Banting and Charles Best released insulin, a birth control method that is critical for regulating glucose levels. This finding was obvious at a critical juncture in diabetes administration, as insulin injections have become a lifesaving situation for things associated with type 1 diabetes
Puerperium and Lactation: The Crucial Phases of Maternal and Infant Health Rehan Haider; Asghar Mehdi; Anjum Zehra
International Journal of Scientific Multidisciplinary Research Vol. 2 No. 1 (2024): January 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/ijsmr.v2i1.7026

Abstract

Puerperium and lactation are critical phases in a woman's life and are characterized by profound physiological and psychological changes. The puerperium, commonly known as the postpartum period, refers to the number of weeks following childbirth when a woman's body undergoes a series of adjustments to return to its non-pregnant state. This phase typically lasts for approximately six weeks but can vary from woman to woman. During puerperium, the uterus contracts, lochia (postpartum discharge) is expelled, and the body gradually recovers from the stress of pregnancy and childbirth. Emotional well-being is also an essential aspect of puerperium, as women often experience a range of emotions and adjustment challenges. Conversely, lactation is the process of producing and providing breast milk to the infants. It is a unique and essential aspect of motherhood, offering numerous health benefits for both the mother and baby. Lactation is primarily regulated by hormones, such as prolactin and oxytocin. Prolactin stimulates milk production, whereas oxytocin triggers milk ejection during breastfeeding. During lactation, the mother's body provides infants with vital nutrients, immunological protection, and emotional bonds through breastfeeding. This natural process also promotes uterine involution, helping the mother recover more quickly after childbirth. Furthermore, breastfeeding has far-reaching health benefits, reducing the risk of various diseases in both mothers and babies
Co-Authors Anjum Zehra Geetha Kumari Geetha Kumari Das Haider, Rehan Rehan Haider Sambreen Zameer Zameer Ahmed